Fiji vs South Africa: Treatment success rate for patients treated for MDR-TB
Fiji
60.0%
in 2022
South Africa
63.0%
in 2022
Fiji rank
120th
South Africa rank
118th
Treatment success rate for patients treated for MDR-TB over time
- Fiji
- South Africa
How they compare
South Africa currently reports 63.0% against 60.0% in Fiji, a difference of 3.0%.
That makes South Africa's figure about 1.1 times Fiji's.
The two have swapped places 1 time across 6 shared years of data; in 2014 it was Fiji ahead.
Fiji ranks 120th and South Africa ranks 118th of 163 countries.
Fiji has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Fiji | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 58.5% | 41.5% | Fiji |
| 2020s | 67.5% | 62.5% | 5.0% | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Fiji or South Africa?
- South Africa, at 63.0% against 60.0% in Fiji as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Fiji and South Africa?
- 3.0%, with South Africa ahead.
- How many years of comparable data are there for Fiji and South Africa?
- 6 years are reported by both, from 2014 to 2022.
- How do Fiji and South Africa rank globally for treatment success rate for patients treated for mdr-tb?
- Fiji ranks 120th and South Africa ranks 118th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.